Source file signed link, expires in 15 minutes
Extracted text 11
Page 1
IMI PT. Jayamas Medica Industri
DISP0SABLE t\4EDICAL DEVICE l'/ANUFACTURER
Tbk
Ka bu paten Sidoarjo,
@nelVlllll
HEALTH CARE
tl luniil u ne2026
Nomor/Number: 0O39IMl-Tbk/DlR/Vll26
Kepada Yth./fo
Kepala Eksekutif Pengawas Pasar Modal
Otoritas Jasa Keuangan (OJKI
Gedung Sumitro Dioiohadikusumo,
Jl. Lapangan Banteng Timur No.2-4
Jakarta 10710
Kepada Yth.lTo
Direksi
PT Burca Efek lndonesia
Gedung Bursa Efek lndonesia
Jl. Jend. Sudirman Kav. 52-53
Jakarta 121!X,
Perihal Hasil Penyelenggaraan Public Expose Re : Results of the Annual Public Expose of PT
Tahunan PT Jayamas Medica lndustri Jayamas Medica lndustri Tbk ("the
Tbk ("Perseroan"f Company'')
Dengan Hormat, Dear Sir,
Mematuhi Peraturan Nomor: l.E. Tentang Kewajiban ln compliance with Regulation No. l.E. on
Penyampaian lnformasi, Lampiran Keputusan Direksi PT Disclosure Obligations, Annex to the Decision of
Bursa Efek lndonesia Nomor Kep-00087/BEllL2-2025 the Board of Directors of PT Bursa Efek lndonesia
tanggal 12 Desember 2O25, butir lll.3 Kewajiban Public No. Kep{fi)87lBEllt2-2025 dated December 12,
Expose dan Surat Edaran Nomor: SE-00003/BE|/05-2020 2025, Section lll. 3 Obligations Regarding Public
perihal Tata Cara Pelaksanaan Public Expose Secara Exposes and Circular Letter No. SE-00003lBEllO5-
Elektroni( bersama ini disampaikan hasil 2O2O regarding Procedures for Conducting
penyelenggaraan Public Expose PT Jayamas Medica Electronic Public Exposes, we hereby submit the
lndustri Tbk yang telah dilaksanakan pada: results of the Public Expose conducted by PT
Jayamas Medica lndustri Tbk, which took place
on:
C(
&NMSffi FM ffi74
l5O 13485: 2016
Ccrt ilo: 01 05 I 2400013/t
o
. TeL +62.31.8982349 I 8985269
c
. Sebetah Setatan Jatan By Pass RI005/RW00l, Sidomojo,
@
. email:
Krian, Sidoarjo, Jawa Timur, lndonesia onemed@onemed.co.id
. fel. +62.321 4890907 . Dusun Karangmenjangan RT.001 /RW.001, Karangwinongan, . website:
Mojoagung, Jombang, Jawa Timur, lndonesia www.onemed.co.id
Page 2
# -qs
Tbk
IMI
Hari / Tanggal
PT. Jayamas Medica lndustri
DISPOSABLE MEDICAL DEVICE MANUFACTURER
: Senin,O8Juni 2026 DaY/ Date
@ne ITFJ:I
H E A LT
: Monday, June 8, 2026
H CAR E
Waktu : Pukul 13.00 - Selesai Time : 1:00 PM - End
Tempat : Offline di PT Jayamas Medica Location : Offline at PT Jayamas Medica
lndusti Tbk, Mojoagung Jombang lndustri Tbk, Mojoagung,
& Online Via Zoom Meeting Jombang & Online via Zoom
Meeting
Demikian informasi ini disampaikan. Atas perhatiannya, This information is hereby conveyed. We thank
kami ucapkan terima kasih. you for your attention.
H ormat Kami / 5 i nce re ly you rs,
PT Jayamas Medica lndustri Tbk
trrEDlC4
,
I
o
o o tr E t
Dra. Herlien Sri Ariani, APT.
Direktur Utama/ Preside nt Directors
C€
brusre FMW4
ISO 13485:2016
Ceil tlo:01 05 B 24000134
o
. Tet. +62.31.8982349 I 8985269
c
. Sebetah Setatan Jatan By Pass RI005/RW001, Sidomojo,
@
. email:
Krian, Sidoarjo, Jawa Timur, lndonesia onemed@onemed.co.id
. fel. +62.321 4890907 . Dusun Karangmenjangan RI001/RW001, Karangwinongan, . website:
Mojoagung, Jombang, Jawa Timur, lndonesia www.onemed.co.id
Page 3
LAPORAN HASIL PELAKSANAAN REPORT ON THE RESULTS OF THE
PUBLIC EXPOSE TAHUNAN ANNUAL PUBLIC EXPOSE
PT JAYAMAS MEDICA INDUSTRI TBK PT JAYAMAS MEDICA INDUSTRI TBK
I. Waktu dan Tempat Public Expose I. Time and Location of the Public Presentation
Hari / Tanggal : Senin, 08 Juni 2026
Day / Date Monday, June 08, 2026
Waktu : 13.00 – Selesai
Time 1:00 PM - End
Tempat : Offline di PT Jayamas Medica Industri Tbk, Mojoagung, Jombang & Online Via
Location Zoom Meeting
Offline at PT Jayamas Medica Industri Tbk, Mojoagung, Jombang & Online via
Zoom Meeting
II. Manajemen Perseroan yang Hadir II. Company Management in Attendance
1. Dewan Komisaris Perseroan 1. The Company's Board of Commissioners
• Komisaris Utama : Yacobus Jemmy Hartanto
President
Commissioners
• Komisaris : Leonard Hariadi Hartanto
Commissioners
• Komisaris Independen : David A. Worth
Independent
Commissioners
2. Direksi Perseroan 2. The Company's Board of Directors
• Direktur Utama : Dra. Herlien Sri Ariani, APT.
President Directors
• Direktur Operasional : Leonard Hariadi Hartanto
Operational Directors
• Direktur Penjualan : Louis Krisnadi Hartanto
dan Pemasaran
Sales and Marketing
Directors
3. Public Expose dihadiri oleh 79 orang peserta 3. The public hearing was attended by 79
dan daftar nama yang hadir terlampir dalam participants; the list of attendees is included
Lampiran 1. in Appendix 1.
Page 4
III. Pelaksanaan Public Expose III. Conduct of the Public Expose
1. Pembukaan Acara: MC membuka acara dan 1. Opening Remarks: The emcee opens the
memperkenalkan jajaran Direksi serta Dewan event and introduces the Company’s Board of
Komisaris Perseroan yang hadir. Directors and Board of Commissioners in
attendance.
2. Pemaparan Kinerja: Dilakukan presentasi 2. Performance Presentation: A presentation on
mengenai kinerja Perseroan. the Company’s performance is given.
3. Sesi Tanya Jawab: Setelah presentasi Public 3. Q&A Session: Following the Public Expose
Expose, acara dilanjutkan dengan sesi tanya presentation, the event continues with a
jawab (Q&A). question-and-answer (Q&A) session.
IV. Materi Paparan IV. Presentation Materials
1. Ringkasan Eksekutif 1. Executive Summary
2. Profil Perusahaan 2. Company Profile
3. Gambaran Bisnis 3. Business Overview
4. Daya Tarik Utama Investasi 4. Key Investment Highlights
5. Strategi Pertumbuhan 5. Growth Strategy
6. Keuangan & Operasional 6. Financials & Operations
7. Aktivitas Perusahaan 7. Company Activities
V. Pertanyaan dan Jawaban Public Expose V. Questions and Answers from the Public Expose
1. Manajemen melaporkan slide 26 bahwa 1. Management reported on slide 26 that
volume Diagnostik & Peralatan melonjak volume in Diagnostics & Equipment surged
577% namun harganya turun 75%, 577% but prices fell 75%, while volume in
sementara Biotech & Lab volumenya turun Biotech & Lab declined but prices rose 239%.
tapi harganya naik 239%. Bisakah Can management explain which products or
manajemen menjelaskan produk atau market trends are driving these two
momentum apa yang mendorong kedua opposing trends?
dinamika yang berlawanan ini?
Jawaban: Answer:
Dinamika yang terjadi pada kedua kategori The dynamics observed in both categories
tersebut disebabkan oleh adanya product mix were driven by the product mix during the
selama kuartal pertama tahun 2026 (1Q26). first quarter of 2026 (1Q26). When comparing
Jika membandingkan antara kedua kategori the two categories, sales in the first quarter of
tersebut, realisasi penjualan pada kuartal 2026 (1Q26) were dominated by items with
pertama tahun 2026 (1Q26) didominasi oleh lower unit values, such as those in the
item-item yang memiliki nilai satuan (value) Diagnostics & Equipment segment.
lebih kecil, sebagai contoh pada segmen
Diagnostik & Peralatan.
Page 5
2. Manajemen melaporkan slide 22 bahwa 2. Management reports on slide 22 that the target produksi massal IOL di Q4 2026, target for mass production of IOL is Q4 2026, sementara slide 27 menunjukkan Cash while slide 27 shows that the cash Conversion Cycle masih 202 hari. Bagaimana conversion cycle remains at 202 days. How manajemen memastikan kebutuhan does management ensure that IOL’s investasi IOL tidak membebeani modal kerja investment needs do not burden the working yang sedang dioptimalkan? capital that is currently being optimized? Jawaban: Answer: Produksi massal IOL pada kuartal keempat Mass production of IOLs in the fourth quarter tahun 2026 (4Q26) tidak akan memberikan of 2026 (4Q26) will not place an additional beban tambahan terhadap modal kerja burden on the Company’s working capital. Perseroan. Hal ini dikarenakan sebagian besar This is because the majority of the capital kebutuhan belanja modal untuk proyek IOL expenditure requirements for the IOL project telah diselesaikan dan dilunasi oleh have already been completed and paid off by Perseroan. Di samping itu, skala investasi the Company. Furthermore, the scale of modal untuk lini ini tidak terlalu tinggi. capital investment for this line is not Namun, fokus manajemen dalam proyek ini particularly high. However, management’s terletak pada penguasaan ilmu yang focus in this project lies on mastering the diperlukan untuk memproduksi instrumen necessary expertise to mass-produce these medis ini secara massal. medical devices. 3. Manajemen melaporkan pertumbuhan 1Q26 3. Management reported very strong growth sangat kuat di slide 28, namun slide 12 for 1Q26 on slide 28, but slide 12 shows that menunjukkan beberapa lini kapasitas masih several production lines are still operating at di bawah 35% utilisasi. Apakah prioritas less than 35% capacity utilization. Is manajemen 12 bulan ke depan adalah management’s priority for the next 12 mengoptimalkan kapasitas yang ada, atau months to optimize existing capacity, or to mempercepat ekspansi ke pasar baru? accelerate expansion into new markets? Jawaban: Answer: Kami mengelola 7 kategori produk utama We manage seven main product categories, yang masing-masing didukung oleh tim each supported by a dedicated operational manajemen operasional khusus. Oleh karena management team. Therefore, itu, priotitas manajemen untuk 12 bulan ke management’s priority for the next 12 depan adalah menerapkan fokus yang months is to maintain a balanced focus across seimbang di seluruh lini produk, mulai dari all product lines, ranging from Medical Bahan Medis Habis Pakai (BMHP) hingga Disposables (BMHP) to Hospital Furniture. Hospital Furniture. Terkait utilisasi kapasitas Regarding production capacity utilization, our produksi, fokus kami berjalan secara paralel, focus proceeds in parallel. For product lines Terhadap lini produk dengan tingkat utilisasi with low utilization rates, our primary focus is yang masih rendah, fokus utama kami adalah to drive sales volume growth to improve the memacu pertumbuhan volume penjualan efficiency of existing capacity. Meanwhile, for guna meningkatkan efisiensi kapasitas yang product lines where production capacity is ada. Sementara untuk lini produk yang nearing its maximum limit, we continue to kapasitas produksinya telah mendekati batas expand and maintain sales momentum to maksimal, kami tetap melakukan ekspansi avoid losing market potential. This combined dan menjaga momentum penjualan agar tidak strategy is implemented to ensure that all
Page 6
kehilangan potensi pasar. Strategi kombinasi product categories can contribute optimally
ini diterapkan demi memastikan seluruh to supporting OneMed Group’s sales growth.
kategori produk mampu memberikan
kontribusi optimal dalam menopang
pertumbuhan penjualan OneMed Group.
4. Melihat situasi saat ini, apakah management 4. Given the current situation, will
akan mengubah forecast revenue growth management revise its 18% revenue growth
18%? Jika tetap, bagaimana cara untuk bisa forecast? If it remains unchanged, how will
tetap bisa mencapai 18% net profir growth? the company still be able to achieve 18% net
profit growth?
Jawaban: Answer:
Hingga saat ini, jajaran Direksi beserta To date, the Board of Directors and
Manajemen belum melakukan perubahan Management have not made any changes to
terhadap target kinerja keuangan the company’s financial performance targets.
perusahaan. Kami tetap berkomitmen pada We remain committed to the initial
proyeksi (forecast) awal yang telah projections that have been set. Management
ditetapkan. Manajemen tetap optimis dapat remains optimistic that it can achieve the 18%
merealisasikan target pertumbuhan revenue growth target.
pendapatan sebesar 18% tersebut.
5. Apa yang menjadi pertimbangan 5. What factors led management to use the
management sehingga management projected growth in government healthcare
menggunakan growth government spending for 2026 as a benchmark for
healthcare spending 2026 sebagai referensi OMED’s revenue growth? Is it because of
untuk OMED revenue growth? Apakah contracts with the government, or are there
karena kontrak dengan Pemerintah, ataukah other calculations involved?
ada hitungan lain?
Jawaban: Answer:
Pertumbuhan anggaran kesehatan The growth in government healthcare
pemerintah (government healthcare spending in 2026 is essentially used by the
spending) pada tahun 2026 pada dasarnya company as one of its macroeconomic
digunakan perusahaan sebagai salah satu indicators. However, OneMed’s revenue
indikator makroekonomi. Namun, proyeksi growth projections are primarily based on the
pertumbuhan pendapatan OneMed company’s internal fundamental calculations.
utamanya disusun berdasarkan kalkulasi The key factors we consider include internal
fundamental internal perusahaan. Komponen production capacity, the readiness of the
utama yang menjadi pertimbangan kami operational team, and sales history.
meliputi kapasitas produksi internal, kesiapan Additionally, achieving these targets will be
tim operasional, serta history penjualan. supported by several growth strategies, such
Selain itu, pencapaian target tersebut akan as retaining customers and diversifying the
ditopang oleh beberapa strategi product portfolio through SKU expansion.
pertumbuhan, seperti menjaga loyalitas Management is also highly optimistic that the
pelanggan (retaining customers) serta operation of the new distribution center, the
melakukan diversifikasi portofolio melalui National Distribution Center (NDC) in Jakarta,
Page 7
penambahan varian produk (SKU expansion). will significantly enhance market penetration Manajemen juga sangat optimis bahwa in the Jakarta area and its surrounding pengoperasian pusat distribusi baru, National regions. The NDC also serves to strengthen Distribution Center (NDC) di Jakarta, akan the supply chain and improve stock secara signifikan meningkatkan penetrasi availability in our various strategic expansion pasar di wilayah Jakarta dan sekitarnya. areas, including Lampung, Batang, and Keberadaan NDC ini juga berfungsi Pontianak. memperkuat rantai pasok dan meningkatkan ketersediaan stok di berbagai wilayah ekspansi strategis kami, termasuk Lampung, Batang, dan Pontianak. 6. Seberapa besar ketergantungan OneMed 6. To what extent does OneMed rely on atas raw material import? imported raw materials? Jawaban: Answer: Terkait dengan eksposur terhadap bahan With regard to exposure to imported raw baku impor dan fluktuasi mata uang asing, materials and foreign exchange fluctuations, kondisi ini merupakan tantangan these conditions represent macroeconomic makroekonomi yang dihadapi oleh industri challenges faced by the national manufaktur nasional secara umum. manufacturing industry in general. Exchange Pergeseran nilai tukar tentu memberikan rate shifts certainly impact our cost structure. dampak pada struktur biaya kami. Namun, However, what sets OneMed apart is the yang membedakan OneMed adalah critical and essential nature of our product karakteristik portofolio produk kami yang portfolio for the healthcare sector, such as bersifat kritikal dan esensial bagi sektor sterile gauze and other Medical Disposables kesehatan, seperti produk kasa steril dan (MD). These products have very high demand Bahan Medis Habis Pakai (BMHP) lainnya. elasticity as they are fundamental to daily Produk-produk ini memiliki elastisitas hospital operations for patient care. Amid permintaan yang sangat tinggi karena these cost dynamics, we are committed to menjadi kebutuhan mendasar dalam ensuring that OneMed products remain the operasional harian rumah sakit guna most competitive and economical choice in menangani pasien. Di tengah dinamika biaya the market, without compromising the tersebut, kami berkomitmen untuk tetap medical quality standards we uphold. menjaga produk OneMed sebagai pilihan yang paling kompetitif dan ekonomis di pasar, tanpa mengorbankan standar kualitas mutu medis yang kami miliki. Dari perspektif manajemen risiko, dinamika From a risk management perspective, global geopolitik global berada di luar kendali geopolitical dynamics are beyond the perusahaan. Namun, OneMed memandang company’s control. However, OneMed views perannya bukan sekadar entitas bisnis yang its role not merely as a business entity mengejar profitabilitas, melainkan sebagai pursuing profitability, but as a critical supplier critical supplier yang memikul tanggung jawab that bears a moral responsibility for human moral terhadap keberlangsungan hidup survival and the operations of the medical manusia dan operasional dunia medis di sector in Indonesia. As a mitigation measure Indonesia. Sebagai langkah mitigasi terhadap against global supply chain risks, including
Page 8
risiko rantai pasok global termasuk potensi potential trade tensions between major ketegangan dagang antar-negara besar, nations, management actively implements a manajemen secara aktif menjalankan strategi supplier diversification strategy (multi- diversifikasi pemasok (multi-sourcing & Plan sourcing & Plan B) from various alternative B) dari berbagai negara alternatif. Langkah countries. We take this strategic step to strategis ini kami lakukan untuk memastikan ensure that stock availability (supply ketersediaan stok (supply kontinuitas) tetap continuity) is maintained in every situation, so terjaga di setiap situasi, sehingga operasional that healthcare operations and patient safety pelayanan kesehatan dan keselamatan pasien in hospitals remain uninterrupted. di rumah sakit tidak terganggu. 7. Bagaimana strategi Manajemen dalam 7. What is management’s strategy for menjaga pangsa pasar mayoritas (market maintaining a majority market share in the share) agar tetap berkelanjutan (sustain) di long term? Additionally, what steps is the masa depan? Serta, langkah-langkah apa company taking to strengthen the loyalty of yang diambil perusahaan untuk memperkuat existing partners so that OneMed’s position loyalitas kemitraan eksisting sehingga posisi as the primary partner remains unchallenged OneMed sebagai mitra utama tidak by competitors? tergantikan oleh kompetitor? Jawaban: Answer: Strategi manajemen dalam mempertahankan Our management strategy for maintaining dominasi pangsa pasar dan memperkuat market share dominance and strengthening loyalitas kemitraan eksisting bertumpu pada loyalty among existing partners is based on tiga pilar utama, yaitu: kualitas produk yang three main pillars: high-quality products, berstandar tinggi, keunggulan layanan service excellence, and competitive pricing. (service excellence), serta struktur harga yang One of the unique value propositions that sets kompetitif. Salah satu nilai tawar unik (unique OneMed apart in this industry is our position value proposition) yang membedakan as a one-stop shopping solution. Our OneMed di industri ini adalah posisi kami extensive product portfolio is capable of sebagai One-Stop Shopping Solution. meeting approximately 70% of a hospital’s Portofolio produk kami yang sangat luas total daily operational needs. This provides mampu memenuhi sekitar 70% dari total significant efficiency for our hospital partners’ kebutuhan operasional harian sebuah rumah procurement departments, as they can sakit. Hal ini memberikan efisiensi yang streamline administrative and logistical signifikan bagi departemen pembelian mitra processes without having to source from rumah sakit, karena mereka dapat various suppliers or different brands. memangkas proses administrasi dan logistik tanpa harus mencari berbagai pemasok atau merek yang berbeda. Di samping itu, komitmen kami diperkuat In addition, our commitment is reinforced by melalui ikatan kontrak jangka panjang dengan long-term contracts with various healthcare berbagai institusi kesehatan, di mana institutions, under which OneMed guarantees OneMed memberikan jaminan ketersediaan continuous product availability. It is also stok secara berkesinambungan. Perlu important to understand that the medical dipahami pula bahwa karakteristik industri device industry is characterized by significant alat kesehatan memiliki hambatan untuk switching barriers. The process of switching
Page 9
beralih (switching barriers) yang cukup tinggi. brands in hospitals requires a significant
Proses pergantian merek di rumah sakit commitment of time and cost, ranging from
membutuhkan komitmen waktu dan biaya clinical trials and product demonstrations to
yang tidak sedikit, mulai dari tahapan uji renegotiation. Given that medical institutions
klinis, demonstrasi produk, hingga negosiasi prioritize consistent quality for patient safety,
ulang. Mengingat institusi medis sangat the stable partnership with OneMed tends to
memprioritaskan konsistensi kualitas demi be long-term and very solid, enabling it to
keselamatan pasien, hubungan kemitraan withstand penetration by new competitors.
yang telah berjalan stabil dengan OneMed
cenderung bersifat jangka panjang dan sangat
solid untuk menghadapi penetrasi dari
kompetitor baru.
Kabupaten Sidoarjo, 11 Juni/June 2026
PT Jayamas Medica Industri Tbk
Dieksi
Page 10
LAMPIRAN 1: APPENDIX 1:
DAFTAR PESERTA PUBLIC EXPOSE LIST OF PARTICIPANTS IN THE PUBLIC EXPOSE
PT JAYAMAS MEDICA INDUSTRI TBK PT JAYAMAS MEDICA INDUSTRI TBK
SENIN, 08 JUNI 2026 MONDAY, JUNE 8, 2026
NAMA LENGKAP KEHADIRAN
NO. STATUS
FULL NAME ATTENDANCE
1 Ade Yolanda INVESTOR RETAIL OFFLINE
2 Aetan INVESTOR RETAIL OFFLINE
3 Ahmad Mustafid INVESTOR RETAIL OFFLINE
4 Albert Kurniawan Willi Tricahya INVESTOR RETAIL OFFLINE
5 Andreas Audy Tjokro Amidjoyo INVESTOR RETAIL OFFLINE
6 Angel Christiana Palit INVESTOR RETAIL OFFLINE
7 Anggela Tjoe INVESTOR RETAIL OFFLINE
8 Anggit Daka Satryadewa INVESTOR RETAIL OFFLINE
9 Annisa Nur Aini INVESTOR RETAIL OFFLINE
10 Antonius Andereas Mario Fanggidae INVESTOR RETAIL OFFLINE
11 Ariq Avicenna Mahdani INVESTOR RETAIL OFFLINE
12 Arron Eugene Raphael Sutikno INVESTOR RETAIL OFFLINE
13 Audy Putri Wulandari INVESTOR RETAIL OFFLINE
14 Carlton Pannagandha Dirgo INVESTOR RETAIL OFFLINE
15 Cathlin Angelika Hutomo INVESTOR RETAIL OFFLINE
16 Choirul Aman INVESTOR RETAIL OFFLINE
17 Daniel INVESTOR RETAIL OFFLINE
18 Daniel INVESTOR RETAIL OFFLINE
19 Debora Rouly Hatiuran Aritonang INVESTOR RETAIL OFFLINE
20 Deddy Febrianto INVESTOR RETAIL OFFLINE
21 Deffandi Nasrul INVESTOR RETAIL OFFLINE
22 Dicky Toti Gunawan Gea INVESTOR RETAIL OFFLINE
23 Dr Yoan Nursari S Shmhum INVESTOR RETAIL OFFLINE
24 Enno Sellya Agustina INVESTOR RETAIL OFFLINE
25 Fenny Herawati Sidharta INVESTOR RETAIL OFFLINE
26 Fiona INVESTOR RETAIL OFFLINE
27 Frank Sugiarto Siek, Se Sh INVESTOR RETAIL OFFLINE
28 Fransisca Yanita Prawitasari INVESTOR RETAIL OFFLINE
29 Gilbert Kresna INVESTOR RETAIL OFFLINE
30 I Gede Enrico Santosa INVESTOR RETAIL OFFLINE
31 Inge Ameylia INVESTOR RETAIL OFFLINE
32 Ira Darmawan INVESTOR RETAIL OFFLINE
33 Irfan Arifudin INVESTOR RETAIL OFFLINE
34 Jaqline Djayakusli INVESTOR RETAIL OFFLINE
35 Jessica Carolina Widodo INVESTOR RETAIL OFFLINE
36 Jessica Febiyola Sondakh INVESTOR RETAIL OFFLINE
37 Jody Friedelisky Toeweh INVESTOR RETAIL OFFLINE
38 Joko Darwianto INVESTOR RETAIL OFFLINE
39 Julia Rachel Waleleng INVESTOR RETAIL OFFLINE
Page 11
40 Kartika Anugrah Handayani INVESTOR RETAIL OFFLINE 41 Krisnawati INVESTOR RETAIL OFFLINE 42 Lisya Jatasiri Christy INVESTOR RETAIL OFFLINE 43 M Diwani Adil Khuza INVESTOR RETAIL OFFLINE 44 M. Abdi Pratama Saputra INVESTOR RETAIL OFFLINE 45 Marcella Adelia INVESTOR RETAIL OFFLINE 46 Marcho Gideon Vicenco Ngongoloy INVESTOR RETAIL OFFLINE 47 Merdian Engge Dokubani INVESTOR RETAIL OFFLINE 48 Michael Lius Balias Tambur INVESTOR RETAIL OFFLINE 49 Muhammad Emirizal INVESTOR RETAIL OFFLINE 50 Nadhi Utoro INVESTOR RETAIL OFFLINE 51 Nadia Margaretha Kendarto INVESTOR RETAIL OFFLINE 52 Nadia Vilda INVESTOR RETAIL OFFLINE 53 Nathaline Christy Ongkowijoyo INVESTOR RETAIL OFFLINE 54 Nathania Valerie Wijaya INVESTOR RETAIL OFFLINE 55 Nazilatur Rizqiyah INVESTOR RETAIL OFFLINE 56 Nixxen Dimitri Hadi INVESTOR RETAIL OFFLINE 57 Oey Vonny Winata INVESTOR RETAIL OFFLINE 58 Padma Gayathri Suryawiramurti INVESTOR RETAIL OFFLINE 59 Prasta Rahandyanto Putra INVESTOR RETAIL OFFLINE 60 Ramdan Ghaseli INVESTOR RETAIL OFFLINE 61 Ramzy Muhammad Basyarahil INVESTOR RETAIL OFFLINE 62 Richard Adrian Limantara INVESTOR RETAIL OFFLINE 63 Rizki Hadiatullah INVESTOR RETAIL OFFLINE 64 Septya Luckyana Putri INVESTOR RETAIL OFFLINE 65 Silfiyana Salsabillah INVESTOR RETAIL OFFLINE 66 Stevanny Oktavia INVESTOR RETAIL OFFLINE 67 Sulfa Chintia Arief INVESTOR RETAIL OFFLINE 68 Tarisah Bahasuan INVESTOR RETAIL OFFLINE 69 Teguh Wibowo ANALIS ONLINE 70 Tiffany Angeline ANALIS ONLINE 71 Valentino Jose Soeyapto ANALIS ONLINE 72 Valentinus Rhesa Sidharta ANALIS ONLINE 73 Velicia Marveline Pranoto INVESTOR RETAIL ONLINE 74 Vincentine Natalie Tanudjaja INVESTOR RETAIL ONLINE 75 Yafet Febrian Valentino Tololiu INVESTOR RETAIL ONLINE 76 Yenti Khofifah Nilam Sari ANALIS ONLINE 77 Yohana Shanta Devi ANALIS ONLINE 78 Yosep Mario Dwi Siswanto ANALIS ONLINE 79 Zidni Mubarok ANALIS ONLINE
Names mentioned 11 people and organisations named in the text · linked when the evidence is strong
unresolved
org
PT. Jayamas Medica Industri DISP
p.1
unresolved
org
ANUFACTURER Tbk
p.1
unresolved
org
PT Burca Efek
p.1
unresolved
org
PT Jayamas Medica
p.1 ×6
unresolved
org
PT Jayamas Medica Location
p.2
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.